References
Garattini, S., and Ghetti, V. (editors): Psychotropic Drugs. Elsevier and Company. Amsterdam. 1957.
Marrazzi, A. S.: Psychosis as a function of disturbed chemical regulation of cerebral synaptic transmission. In: Chemical Concepts of Psychosis. M. Rinkel and H. C. B. Denber, editors, P. 305. McDowell, Obolensky. New York. 1958.
Denber, H. C. B., and Merlis, S.: Studies on mescaline V.: Antagonism between mescaline and chlorpromazine. In: Psychopharmacology, Publication No. 42, P. 141. American Association for the Advancement of science, Washington, D.C. 1956.
Denber, H. C. B.: Studies on mescaline III: Action in epileptics.Psychiat. Quart., 29:433, July 1955.
Schwarz, E.; Bickford, R. G., and Rome, H. P.: Reversibility of induced psychosis with chlorpromazine. Proc. Staff Meet. Mayo Clin., 30:407, September 1955.
Hoch, P. H.: Psychoses-producing and psychoses-relieving drugs. In: The Brain and Human Behavior. A.R.N.D. P. 335. Williams and Wilkins. Baltimore. 1958.
Fabing, H. D.: Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis. Neurology, 5:319, May 1955.
Denber, H. C. B.: Drug-induced states resembling naturally occurring psychoses. In: Psychotropic Drugs. S. Garattini and V. Ghetti, editors. P. 26. Elsevier and Company. Amsterdam. 1957.
Denber, H. C. B.: Studies on mescaline IX: Comparative action of various drugs on the mescaline-induced state. In: Biological Psychiatry. J. Masserman, editor. P. 203. Grune & Stratton. New York. 1959.
Denber, H. C. B.: Studies on mescaline VII: The role of anxiety in the mescaline-induced state and its influence on the therapeutic results. J. N. M. D., 124:74, July 1956.
Deniker, P.: Biological changes in man following intravenous administration of mescaline. J. N. M. D., 125:427, July–September 1957.
Bleuler, M.: Panel discussion. In: Neuro-Psychopharmacology, P. B. Bradley, P. Deniker, and C. Radouco-Thomas, editors. P. 161. Elsevier and Company. Amsterdam. 1959.
Troll, W., and Cannan, R. K.: A modified photometric ninhydrin method for the analysis of amino and imino acids. J. Biol. Chem., 200:803, February 1953.
Zlatkis, A.; Zak, B. and Boyle, A. J.: A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med., 41:486, March 1953.
Denber, H. C. B., and Merlis, S.: Studies on mescaline VI: Therapeutic aspects of the mescaline-chlorpromazine combination. J. N. M. D., 122:463, November 1955.
Merlis, S.: The effect of mescaline sulfate in chronic schizophrenia. J. N. M. D., 125:432, July –September 1957.
Denber, H. C. B.: Studies on mescaline VIII: Psychodynamic observations. Am. J. Psychiat., 115:239, September 1958.
Block, W.: Pharmacological aspects of mescaline. In: Chemical Concepts of Psychosis. M. Rinkel and H. C. B. Denber, editors. P. 106. McDowell, Obolensky. New York. 1958.
Mayer-Gross, W.; McAdam, W., and Walker, J.: Lysergsäure-diäthylamid und kohlenhydratstoffwechsel. Nervenarzt, 23:30, January 1952.
Richter, D.: Biochemical aspects of schizophrenia. In: Schizophenia—Somatic Aspects. D. Richter, editor. P. 53. Macmillan. New York. 1957.
Georgi, F.; Honegger, C. G.; Jordan, D.; Rieder, H. P., and Rottenberg, N.: Investigations in protein metabolism in nervous and mental diseases with special reference to the metabolism of amines. Int. Rev. Neurobiol., 1:343, 1959.
Grundy, S. M., and Griffin, A. C.: Relationship of periodic mental stress to serum lipoprotein and cholesterol levels. J.A.M.A., 171:1794, November 1959.
Author information
Authors and Affiliations
Additional information
These studies were carried out in the research division of Manhattan (N.Y.) State Hospital, and this report was presented at the symposium, “The Problem of Antagonists to Psychotropic Drugs,” Collegium Internationale Neuro-Psychopharmacologicum, Basle, Switzerland, July 4–7, 1960.
Rights and permissions
About this article
Cite this article
Denber, H.C.B. Studies on mescaline XI: Biochemical findings during the mescaline-induced state with observations on the blocking action of different psychotropic drugs. Psych Quar 35, 18–48 (1961). https://doi.org/10.1007/BF01572555
Issue Date:
DOI: https://doi.org/10.1007/BF01572555